US-based healthcare management and operations company Nutex Health has opened its newest microhospital in Mandeville, Louisiana.
The Covington Trace ER & Hospital is the third hospital that Nutex Health has opened this year, with the company planning to open more hospitals later in the year.
Covering 21,000ft², the facility will operate at all hours throughout the year.
It features an emergency room with eight private exam rooms, as well as ten private inpatient beds, in-house imaging, pharmacy and laboratory services.
In addition to the Covington Trace ER & Hospital, Nutex Health also owns the Alexandria Emergency Hospital in Alexandria.
Earlier this year, the company opened an urgent care centre in Alhambra, California.
Nutex Health chairman and CEO Tom Vo said: “We are honoured by the opportunity to bring our brand of medicine to the North Shore.
“Our mission is to bring more accessibility to healthcare, and we look forward to serving the communities of Covington, Mandeville, Hammond, Slidell and beyond.
“The Covington facility marks our third new hospital opening year-to-date, following Fort Smith and Albuquerque, moving us closer to achieving our 2023 target of 5-6 new hospital openings.”
Nutex Health’s cloud-based proprietary technology integrates clinical and claims data to provide comprehensive insights for patients and healthcare providers.
The company has two units, namely Hospital Division and Population Health Management Division.
Its Hospital Division owns and runs ‘innovative’ healthcare models such as micro-hospitals, speciality hospitals and hospital outpatient departments.
The unit currently operates 21 facilities across eight US states.
Nutex Health's Population Health Management unit owns and runs provider networks such as Independent Physician Associations.
The company recently integrated VinBrain’s DrAid Chest XR, a diagnostic imaging solution powered by artificial intelligence, into its radiology workflow as part of a software subscription licence agreement.
DrAid Chest XR's positive impact had been assessed in a 90-day trial in Nutex’s Emergency Radiology department.
